Emergent BioSolutions, Inc. (EBS)
8.15
+0.09
(+1.12%)
USD |
NYSE |
May 20, 16:00
8.10
-0.05
(-0.61%)
After-Hours: 16:39
Emergent BioSolutions Market Cap : 420.51M for May 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.586B |
| Alnylam Pharmaceuticals, Inc. | 39.84B |
| Amgen, Inc. | 179.06B |
| Savara, Inc. | 1.042B |
| Biogen, Inc. | 27.73B |
Market Cap Related Metrics
| PS Ratio | 0.6611 |
| Price to Book Value | 0.8039 |
| Price to Free Cash Flow | 3.305 |
| Price | 8.15 |
| Earnings Yield | -3.47% |
| Operating PE Ratio | 6.284 |